CHE vs ENSG vs PHG Stock Comparison

Chemed, Ensign and Koninklijke Philips Prices as of Oct 26, 2026 Peers: Industry group

Rank against

CHE Chemed Corp

$513.32 +0.3% 1M +17.6% 1Y

Market cap: $6.70B
P/E: 24.4x
Revenue (TTM): $2.60B
Div. yield: 0.00%

3 wins

ENSG Ensign Group, Inc

$176.92 +1.0% 1M -4.9% 1Y

Market cap: $9.84B
P/E: 26.0x
Revenue (TTM): $5.49B
Div. yield: –

4 wins

PHG Koninklijke Philips Nv

$26.56 +6.4% 1M -7.9% 1Y

Market cap: $25.07B
P/E: 13.6x
Revenue (TTM): $20.60B
Div. yield: –

4 wins

Head to Head

11 decided of 12

Koninklijke Philips leads on 4 of the 12 questions below (Koninklijke Philips 4, Ensign 4, Chemed 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

Question	CHE	ENSG	PHG	Leader
Larger companyMarket capitalisation	$6.70B	$9.84B	$25.07B	PHG
Cheaper on earningsLower P/E, profitable companies only	24.4x	26.0x	13.6x	PHG
Cheaper on forward earningsLower price / next fiscal year consensus EPS	19.4x	21.3x	13.4x	PHG
Faster revenue growthRevenue growth, trailing twelve months	+3.3%	+18.9%	+6.1%	ENSG
More profitableNet margin, trailing twelve months	10.6%	6.9%	8.9%	CHE
Better return on capitalReturn on invested capital	27.2%	13.9%	11.5%	CHE
Less leveragedLower net debt / EBITDA	0.2x	-0.3x	1.8x	ENSG
Higher dividend yieldTrailing dividend yield	0.00%	0.00%	0.00%	–
Better 1-year returnPrice return, last 12 months	+17.6%	-4.9%	-7.9%	CHE
Better 5-year returnAnnualised price return, 5 years	+3.1%/yr	+20.6%/yr	-10.8%/yr	ENSG
Less volatileAnnualised volatility, 1 year	29.9%	27.8%	28.8%	ENSG
Higher overall scoreMean of the five percentile scores vs peers	59/100	61/100	80/100	PHG

Percentile Scorecard

CHEENSGPHG

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

Axis	CHE	ENSG	PHG
Valuation	57 #41 of 93	65 #33 of 93	98 #6 of 228
Growth	14 #76 of 88	59 #37 of 88	96 #11 of 221
Profitability	92 #8 of 87	71 #26 of 87	96 #10 of 208
Financial Health	67 #34 of 100	73 #28 of 100	31 #166 of 239
Shareholder Returns	64 #21 of 56	40 #34 of 56	79 #29 of 137
Overall	59	61	80

CHE ranked among 103 companies in Healthcare Providers
ENSG ranked among 103 companies in Healthcare Providers
PHG ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

Period	CHE	ENSG	PHG	SPY
1 month	+0.3%	+1.0%	+6.4%	-0.8%
3 months	+0.9%	-0.6%	+6.2%	+3.5%
6 months	+21.4%	-6.9%	-3.6%	+7.0%
Year to date	+20.0%	+1.6%	-1.9%	+12.2%
1 year	+17.6%	-4.9%	-7.9%	+13.0%
3 years	-9.1%	+81.8%	+43.6%	+86.3%
3 years, per year	-3.1%	+22.1%	+12.8%	+23.1%
5 years	+16.2%	+155.5%	-43.6%	+68.6%
5 years, per year	+3.1%	+20.6%	-10.8%	+11.0%
10 years	+275.9%	+886.2%	-11.6%	+258.0%
10 years, per year	+14.2%	+25.7%	-1.2%	+13.6%

Risk

Measure	CHE	ENSG	PHG	SPY
Volatility, 1Y	29.9%	27.8%	28.8%	12.7%
Downside volatility, 1Y	33.3%	24.3%	28.8%	12.7%
Beta vs S&P 500, 1Y	0.01	-0.06	0.81	1.00
Return / volatility, 1Y	0.59	-0.18	-0.27	1.02
Max drawdown, 5Y	-43.4%	-31.8%	-75.6%	-25.4%
From 52-week high	-7.1%	-18.0%	-19.3%	-1.8%
52-week high	$552.43	$215.83	$32.91	$779.14
52-week low	$368.59	$147.13	$23.81	$631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

Multiple	CHE	ENSG	PHG
P/E now vs peer median	24.6xmedian 25.1x	27.1xmedian 25.1x	13.7xmedian 30.6x
P/S now vs peer median	2.6xmedian 1.6x	1.9xmedian 1.6x	1.2xmedian 3.0x
EV/EBITDA now vs peer median	16.4xmedian 14.5x	17.4xmedian 14.5x	8.1xmedian 17.5x
P/FCF now vs peer median	20.7xmedian 22.4x	24.6xmedian 22.4x	5.9xmedian 23.3x
P/B now vs peer median	8.1xmedian 3.1x	4.2xmedian 3.1x	2.0xmedian 2.4x
PEG now vs peer median	2.07median 0.66	1.82median 0.66	0.32median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve months	CHE	ENSG	PHG
Revenue	$2.60B	$5.49B	$20.60B
Gross profit	$859.31M	$1.14B	$16.03B
Operating income	$349.19M	$467.39M	$2.65B
Net income	$274.99M	$378.95M	$1.39B
Free cash flow	$323.61M	$419.09M	$4.34B
R&D	–	–	$2.00B
EPS (diluted)	$20.83	$6.37	$1.91
Cash & equivalents	$40.22M	$262.30M	$2.04B
Total debt	$140.00M	$566.98M	$9.51B
Shares (diluted)	13.20M	59.48M	962.50M
Enterprise value	$6.44B	$7.84B	$14.18B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics

Metric	CHE	ENSG	PHG
P/E	24.6x	27.1x	13.7x
P/FCF	20.7x	24.6x	5.9x
P/Operating cash flow	17.2x	16.9x	9.6x
P/S	2.6x	1.9x	1.2x
P/B	8.1x	4.2x	2.0x
P/Tangible book	8.9x	4.2x	2.5x
EV/EBITDA	16.4x	17.4x	8.1x
EV/EBIT	19.5x	21.7x	12.4x
EV/Revenue	2.6x	1.8x	1.6x
EV/FCF	21.0x	24.2x	7.6x
EV/Operating cash flow	17.5x	16.6x	12.4x
PEG (3Y EPS CAGR)	2.07	1.82	0.32

Growth

14 metrics

Metric	CHE	ENSG	PHG
Revenue growth (1Y)	3.3%	18.9%	6.1%
Revenue CAGR (3Y)	5.9%	17.4%	2.3%
Gross profit growth (1Y)	1.7%	18.7%	82.4%
Gross profit CAGR (3Y)	4.8%	15.7%	6.7%
Operating income growth (1Y)	-5.3%	18.2%	121.3%
Operating income CAGR (3Y)	4.7%	15.6%	52.0%
Net income growth (1Y)	-5.3%	17.3%	293.5%
Net income CAGR (3Y)	6.7%	16.4%	35.6%
EPS growth (1Y)	5.5%	15.6%	539.4%
EPS CAGR (3Y)	11.9%	14.9%	42.2%
Operating cash flow growth (1Y)	-8.6%	31.4%	116.7%
Operating cash flow CAGR (3Y)	4.2%	25.1%	53.6%
Free cash flow growth (1Y)	-12.9%	51.4%	54.2%
Free cash flow CAGR (3Y)	5.0%	26.2%	45.6%

Profitability

14 metrics

Metric	CHE	ENSG	PHG
Gross margin	33.1%	20.7%	77.8%
EBITDA margin	16.0%	10.6%	19.8%
Operating margin	13.5%	8.5%	12.9%
Pretax margin	14.2%	9.1%	11.9%
Net margin	10.6%	6.9%	8.9%
FCF margin	12.5%	7.6%	21.1%
Operating cash flow margin	15.0%	11.1%	12.9%
Return on equity	32.8%	15.7%	12.7%
Return on assets	17.7%	6.7%	5.4%
Return on invested capital	27.2%	13.9%	11.5%
Return on capital employed	28.2%	9.7%	11.8%
Asset turnover	1.7x	1.0x	0.7x
Cash conversion (OCF / net income)	1.4x	1.6x	1.9x
Stock comp / revenue	1.3%	1.0%	0.7%

Financial Health

11 metrics

Metric	CHE	ENSG	PHG
Debt / assets	8.9%	2.4%	31.2%
Debt / equity	0.2x	0.1x	0.7x
Net debt / EBITDA	0.2x	-0.3x	1.8x
Debt / FCF	0.4x	0.3x	2.2x
Liabilities / assets	47.4%	57.5%	57.1%
Equity / assets	52.6%	42.5%	42.9%
Interest coverage	106.5x	60.0x	6.2x
Current ratio	0.9x	1.2x	1.3x
Quick ratio	0.7x	1.1x	0.7x
Cash ratio	0.1x	0.4x	0.2x
Altman Z-score	10.45	3.61	–

Shareholder Returns

7 metrics

Metric	CHE	ENSG	PHG
Dividend yield	0.5%	0.2%	3.7%
Net buyback yield	9.5%	0.1%	-0.5%
Shareholder yield	10.0%	0.2%	3.3%
Payout ratio (earnings)	12.1%	–	–
Payout ratio (FCF)	10.3%	–	–
Dividend growth (1Y)	12.4%	–	–
Dividend CAGR (3Y)	13.5%	–	–

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

Consensus	CHE	ENSG	PHG
Forward P/E	19.4xFY2026	21.3xFY2026	13.4xFY2026
EPS, next fiscal year	$26.52FY2026	$8.29FY2026	$1.98FY2026
EPS growth, next FY	+23.1%FY2026	+26.2%FY2026	+6.5%FY2026
EPS growth, the year after	+8.0%	-1.8%	-10.1%
Revenue, next fiscal year	$2.66BFY2026	$5.76BFY2026	$21.63BFY2026
Revenue growth, next FY	+5.1%FY2026	+13.9%FY2026	+1.8%FY2026
Revenue growth, the year after	+15.2%	+16.9%	-8.2%

CHE estimates →ENSG estimates →PHG estimates →

Institutional Ownership

13F filings, quarter ended Jun 30, 2026

Holders	CHE	ENSG	PHG
Held by institutions	100.0%	89.8%	5.4%
Institutions holding	527	547	363
Change in shares held, QoQ	+2.8%	-1.2%	+0.8%
Institutions buying	276	250	266
Institutions selling	186	213	76
Buyers to sellers	1.48	1.17	3.50

CHE holders →ENSG holders →PHG holders →

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

	CHE	ENSG	PHG
CHE	1.00	0.34	0.08
ENSG	0.34	1.00	0.15
PHG	0.08	0.15	1.00

Add a Peer

Largest companies in the same industry

CHE · Home Health and Senior Care

+BTSGBrightSpring Health Services +PACSPacs +OPCHOption Care Health +NHCNational Healthcare +AVAHAveanna Healthcare Holdings +BKDBrookdale Senior Living +ADUSAddus HomeCare +SNDASonida Senior Living

Plot all 9 Home Health and Senior Care stocks → Plot all 58 Diagnostic Equipment stocks →

Related Comparisons

CHE vs BTSGBrightSpring Health Services CHE vs PACSPacs CHE vs OPCHOption Care Health CHE vs NHCNational Healthcare

Frequently Asked Questions

Which is bigger, CHE, ENSG and PHG?

Koninklijke Philips (PHG) is the largest by market capitalisation: Chemed (CHE) $6.70B, Ensign (ENSG) $9.84B, Koninklijke Philips (PHG) $25.07B.

Which stock is cheaper, CHE, ENSG and PHG?

Koninklijke Philips (PHG) trades on the lowest price-to-earnings ratio (Chemed (CHE) 24.4x, Ensign (ENSG) 26.0x, Koninklijke Philips (PHG) 13.6x). On next year's consensus earnings, Koninklijke Philips (PHG) is cheapest (Chemed (CHE) 19.4x, Ensign (ENSG) 21.3x, Koninklijke Philips (PHG) 13.4x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Ensign (ENSG) grew revenue fastest over the trailing twelve months: Chemed (CHE) +3.3%, Ensign (ENSG) +18.9%, Koninklijke Philips (PHG) +6.1%.

Which company is more profitable?

Chemed (CHE) has the highest net margin (Chemed (CHE) 10.6%, Ensign (ENSG) 6.9%, Koninklijke Philips (PHG) 8.9%). On return on invested capital, Chemed (CHE) leads (Chemed (CHE) 27.2%, Ensign (ENSG) 13.9%, Koninklijke Philips (PHG) 11.5%).

Which stock has performed better?

Over the past year Chemed (CHE) returned the most: Chemed (CHE) +17.6%, Ensign (ENSG) -4.9%, Koninklijke Philips (PHG) -7.9%. Over five years, Ensign (ENSG) compounded fastest (Chemed (CHE) +3.1%/yr, Ensign (ENSG) +20.6%/yr, Koninklijke Philips (PHG) -10.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Chemed (CHE) 0.00%, Ensign (ENSG) 0.00%, Koninklijke Philips (PHG) 0.00%. Ensign (ENSG) and Koninklijke Philips (PHG) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Ensign (ENSG) has been the steadiest (Chemed (CHE) 29.9%, Ensign (ENSG) 27.8%, Koninklijke Philips (PHG) 28.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CHE, ENSG and PHG?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Koninklijke Philips (PHG) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.

CHE vs ENSG vs PHG

Stock Comparison · Prices as of Oct 26, 2026

CHE $513.32 +0.3% 1M ENSG $176.92 +1.0% 1M PHG $26.56 +6.4% 1M